Prescience Point Capital Management Releases Presentation Detailing Board And Management Failures at MiMedx Group
prnewswire.com
news
2022-05-31 18:05:00

Votes WITHHOLD against board directors Phyllis Gardner and James Bierman at 2022 Annual Meeting to send a message to MiMedx Demands Management and the Board Show Confidence in MiMedx and Alignment With Shareholders' Interests by PURCHASING SHARESWill Vote AGAINST Approval of Executive Compensation Following Egregious Share Grants to ManagementBATON ROUGE, La., May 31, 2022 /PRNewswire/ -- Prescience Point Capital Management LLC ("Prescience Point"), a research-focused, catalyst-driven investment firm that beneficially owns approximately 6.
